15

GROWING THE RESPONSIBLE USE OF MEDICINES

What can be done to ensure that children are treated with

the most appropriate products? FIP has been lending its

expertise to the preparation of a joint document with the

WHO that will help guide alternatives to compounding

for children.

FIP s standards for hospital pharmacy (Basel Statements

2008) have been adopted in many places and have had

various indirect influences. However, to keep current

with changes in practice, they are being revised.

The first FIP UNESCO-UNITWIN Centre of Excellence, part of the

FIPEd 5-year Action Plan, is well under way to being launched.

FIP s Statement on Code of Ethics (2004) is being revised

so that it reflects new challenges. It is expected that the

report on ethics and autonomy in pharmacy (as well as

a revised statement) will be put forward for adoption by

the Council at the congress in Bangkok.

A new working group of the Pharmacy Information Section

is looking into national strategic plans for the development and

use of medicines information.

In addition to work on the programmes for future conferences (Düsseldorf 2015 and Buenos Aires 2016), regular newsletters to members, and activities on discussion forums, work in progress at FIP includes the following.

SETTING STANDARDS FOR CHILDREN S MEDICINES

REFLECTING CHANGES IN HOSPITAL PRACTICE

ESTABLISHING CENTRES OF EXCELLENCE

KEEPING ETHICS UP TO DATE

PROVIDING TOOLS FOR BETTER MEDICINES INFORMATION

WORK IN PROGRESS

July 2013 saw the first convening of the FIP working group on

remuneration models for hospital and community pharmacies.

High- quality pharmaceutical care services are a must for

achieving responsible use of medicines, but a crucial cog is a

sustainable and supportive economic system that is properly

integrated in healthcare systems at national or provincial level

in order to fund these services.

ENABLING HIGH-QUALITY PHARMACEUTICAL SERVICES

read more

read more

read more